does hims sell semaglutide & Hers shares fall after FDA says no longer in shortage Hims & Hers Launches New

Zepbound (tirzepatide) is an FDA-approved medication for chronic weight management that works by activating GIP and GLP-1 receptors to reduce appetite and slow gastric emptying

The ability to go extended periods without hunger or eating, while pharmacologically useful for weight loss, can reinforce dangerous behaviors in vulnerable individuals

Their primary biological activity is mediated by receptors belonging to the nuclear receptor superfamily, which function as transcription factors that modulate gene expression

Thus, there is an intense interest to design more potent antibody formats, where long plasma half-life is a commercially competitive differentiator affecting dosing, frequency of administration and thereby potentially patient compliance